Globus Medical (NYSE:GMED) & H-CYTE (OTCMKTS:HCYTD) Head to Head Analysis

Globus Medical (NYSE:GMED) and H-CYTE (OTCMKTS:HCYTD) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their profitability, institutional ownership, dividends, valuation, analyst recommendations, earnings and risk.

Valuation and Earnings

This table compares Globus Medical and H-CYTE’s top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Globus Medical	$1.02 billion	7.12	$122.87 million	$1.17	45.86
H-CYTE	$1.61 million	0.32	-$4.80 million	N/A	N/A

Globus Medical has higher revenue and earnings than H-CYTE.

Insider and Institutional Ownership

95.2% of Globus Medical shares are held by institutional investors. 24.3% of Globus Medical shares are held by company insiders. Comparatively, 5.2% of H-CYTE shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Analyst Recommendations

This is a summary of recent ratings and target prices for Globus Medical and H-CYTE, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Globus Medical	0	3	6	0	2.67
H-CYTE	0	0	0	0	N/A

Globus Medical presently has a consensus price target of $66.33, suggesting a potential upside of 23.64%. Given Globus Medical’s higher possible upside, research analysts clearly believe Globus Medical is more favorable than H-CYTE.

Risk and Volatility

Globus Medical has a beta of 1.09, meaning that its stock price is 9% more volatile than the S&P 500. Comparatively, H-CYTE has a beta of 1.12, meaning that its stock price is 12% more volatile than the S&P 500.

Profitability

This table compares Globus Medical and H-CYTE’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Globus Medical	7.83%	8.82%	7.20%
H-CYTE	-450.40%	N/A	-777.68%

Summary

Globus Medical beats H-CYTE on 10 of the 11 factors compared between the two stocks.

About Globus Medical

Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative and congenital conditions, deformity, tumors, and trauma injuries; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional solutions to treat vertebral compression fractures; and regenerative biologic products comprising of allografts and synthetic alternatives. It also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and hip and knee joint solutions, including modular hip stems and acetabular cups, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants. In addition, the company distributes human cell, tissue, and cellular and tissue-based products. It sells its products through direct or distributor sales representatives, as well as hip and knee products through independent sales agents. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.

About H-CYTE

H-CYTE, Inc., a biopharmaceutical company, develops and delivers various treatments for patients with chronic respiratory and pulmonary disorders in the United States. The company develops and implements treatment options in autologous cellular therapy to treat chronic lung disorders. It has a product supply agreement with Rion, LLC to develop and distribute a biologic for chronic obstructive pulmonary disease. The company is headquartered in Tampa, Florida.